These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 35008700)

  • 1. Human iPSC-Derived Astrocytes: A Powerful Tool to Study Primary Astrocyte Dysfunction in the Pathogenesis of Rare Leukodystrophies.
    Lanciotti A; Brignone MS; Macioce P; Visentin S; Ambrosini E
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glial cells in the driver seat of leukodystrophy pathogenesis.
    Garcia LM; Hacker JL; Sase S; Adang L; Almad A
    Neurobiol Dis; 2020 Dec; 146():105087. PubMed ID: 32977022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukodystrophies with astrocytic dysfunction.
    Rodriguez D
    Handb Clin Neurol; 2013; 113():1619-28. PubMed ID: 23622383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Astrocyte Subtype Vulnerability in Stem Cell Models of Vanishing White Matter.
    Leferink PS; Dooves S; Hillen AEJ; Watanabe K; Jacobs G; Gasparotto L; Cornelissen-Steijger P; van der Knaap MS; Heine VM
    Ann Neurol; 2019 Nov; 86(5):780-792. PubMed ID: 31433864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell Replacement Therapy Improves Pathological Hallmarks in a Mouse Model of Leukodystrophy Vanishing White Matter.
    Dooves S; Leferink PS; Krabbenborg S; Breeuwsma N; Bots S; Hillen AEJ; Jacobs G; van der Knaap MS; Heine VM
    Stem Cell Reports; 2019 Mar; 12(3):441-450. PubMed ID: 30799272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An update on clinical, pathological, diagnostic, and therapeutic perspectives of childhood leukodystrophies.
    Ashrafi MR; Amanat M; Garshasbi M; Kameli R; Nilipour Y; Heidari M; Rezaei Z; Tavasoli AR
    Expert Rev Neurother; 2020 Jan; 20(1):65-84. PubMed ID: 31829048
    [No Abstract]   [Full Text] [Related]  

  • 7. Modeling vanishing white matter disease with patient-derived induced pluripotent stem cells reveals astrocytic dysfunction.
    Zhou L; Li P; Chen N; Dai LF; Gao K; Liu YN; Shen L; Wang JM; Jiang YW; Wu Y
    CNS Neurosci Ther; 2019 Jun; 25(6):759-771. PubMed ID: 30720246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Astroglia in Leukodystrophies.
    Jorge MS; Bugiani M
    Adv Exp Med Biol; 2019; 1175():199-225. PubMed ID: 31583590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vanishing white matter: a leukodystrophy due to astrocytic dysfunction.
    Bugiani M; Vuong C; Breur M; van der Knaap MS
    Brain Pathol; 2018 May; 28(3):408-421. PubMed ID: 29740943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The neurovascular unit in leukodystrophies: towards solving the puzzle.
    Zarekiani P; Nogueira Pinto H; Hol EM; Bugiani M; de Vries HE
    Fluids Barriers CNS; 2022 Feb; 19(1):18. PubMed ID: 35227276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. White matter astrocytes in health and disease.
    Lundgaard I; Osório MJ; Kress BT; Sanggaard S; Nedergaard M
    Neuroscience; 2014 Sep; 276():161-73. PubMed ID: 24231735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ASTROCYTES: EMERGING STARS IN LEUKODYSTROPHY PATHOGENESIS.
    Lanciotti A; Brignone MS; Bertini E; Petrucci TC; Aloisi F; Ambrosini E
    Transl Neurosci; 2013 Jun; 4(2):. PubMed ID: 24340223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Affected astrocytes in the spinal cord of the leukodystrophy vanishing white matter.
    Leferink PS; Breeuwsma N; Bugiani M; van der Knaap MS; Heine VM
    Glia; 2018 Apr; 66(4):862-873. PubMed ID: 29285798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secretomics Alterations and Astrocyte Dysfunction in Human iPSC of Leukoencephalopathy with Vanishing White Matter.
    Deng J; Zhang J; Gao K; Yan W; Zhou L; Jiang Y; Wang J; Wu Y
    Neurochem Res; 2022 Dec; 47(12):3747-3760. PubMed ID: 36198922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amelioration of Huntington's disease phenotype in astrocytes derived from iPSC-derived neural progenitor cells of Huntington's disease monkeys.
    Cho IK; Yang B; Forest C; Qian L; Chan AWS
    PLoS One; 2019; 14(3):e0214156. PubMed ID: 30897183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human Astrocytes Model Derived from Induced Pluripotent Stem Cells.
    Leventoux N; Morimoto S; Imaizumi K; Sato Y; Takahashi S; Mashima K; Ishikawa M; Sonn I; Kondo T; Watanabe H; Okano H
    Cells; 2020 Dec; 9(12):. PubMed ID: 33322219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of GFAP::GFP astrocyte reporter lines from human adult fibroblast-derived iPS cells using zinc-finger nuclease technology.
    Zhang PW; Haidet-Phillips AM; Pham JT; Lee Y; Huo Y; Tienari PJ; Maragakis NJ; Sattler R; Rothstein JD
    Glia; 2016 Jan; 64(1):63-75. PubMed ID: 26295203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Astrocytes generated from patient induced pluripotent stem cells recapitulate features of Huntington's disease patient cells.
    Juopperi TA; Kim WR; Chiang CH; Yu H; Margolis RL; Ross CA; Ming GL; Song H
    Mol Brain; 2012 May; 5():17. PubMed ID: 22613578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Efficient Platform for Astrocyte Differentiation from Human Induced Pluripotent Stem Cells.
    Tcw J; Wang M; Pimenova AA; Bowles KR; Hartley BJ; Lacin E; Machlovi SI; Abdelaal R; Karch CM; Phatnani H; Slesinger PA; Zhang B; Goate AM; Brennand KJ
    Stem Cell Reports; 2017 Aug; 9(2):600-614. PubMed ID: 28757165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of human iPSC-derived astrocytes with potential for disease modeling and drug discovery.
    Soubannier V; Maussion G; Chaineau M; Sigutova V; Rouleau G; Durcan TM; Stifani S
    Neurosci Lett; 2020 Jul; 731():135028. PubMed ID: 32380146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.